Welcome
Support Centre
04 July 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Psychotherapeutic INtervention for DEpression Treatment in patients with chronic Heart Failure
ISRCTN ISRCTN74936396
ClinicalTrials.gov identifier
Public title Psychotherapeutic INtervention for DEpression Treatment in patients with chronic Heart Failure
Scientific title
Acronym PINDET-HF
Serial number at source PINDET-HF - 01GI0205/21
Study hypothesis Psychotherapeutic treatment in patients with chronic heart failure and comorbid depression leads to a significant reduction of depression severity in comparison to usual care.
Ethics approval Ethical approval for the study was obtained from the institutional review board of the medical faculty of the University of Heidelberg on the 5th March 2007 (ref.: 302/2006)
Study design Randomised controlled intervention trial
Countries of recruitment Germany
Disease/condition/study domain Chronic heart failure, depression
Participants - inclusion criteria 1. Outpatients with documented, stable chronic heart failure
2. New York Heart Association (NYHA) functional class I to III
3. Any depressive disorder or major depressive disorder according to 9-item Patient Health Questionnaire (PHQ-9) AND dysthymia or adjustment disorder or major depressive disorder with mild or medium severity according to Structured Clinical Interview for Depression Interview (SCID-I)
4. Age equal or greater than 18 years
Participants - exclusion criteria 1. Acute physical illness that makes participation impossible, according to investigator's assessment
2. Participation in other clinical intervention trial
3. Dementia or other psychiatric disorder, that compromise patients' abilities to study compliance
4. Alcohol or drug abuse
5. Severe major depressive disorder
6. Acute suicidal tendency
7. Current psychotherapeutic treatment
Anticipated start date 01/01/2007
Anticipated end date 31/05/2008
Status of trial Completed
Patient information material
Target number of participants 130
Interventions Eight sessions in a psychotherapy group (six to nine patients per group), 90 minutes each, over three months, versus care as usual (patients are informed about depression diagnosis and are motivated to talk about treatment options with their GP). Psychotherapy is based on cognitive behavioural techniques and follows a manual. Elements of therapy are:
1. Psychoeducation
2. Cognitive techniques
3. Setup of positive activities
4. Relaxation skills
5. Keeping a study diary
Primary outcome measure(s) Depression severity according to PHQ-9 summary score at the end of the intervention.
Secondary outcome measure(s) 1. PHQ-9 summary score three months after the intervention
2. Generic (36-item Short Form health survey [SF-36]) and disease-specific (Kansas City Cardiomyopathy Questionnaire [KCCQ]) quality of life
3. Anxiety severity (7-item Generalised Anxiety Disorder scale [GAD-7])
4. Resilience (Resilience Scale)
5. Hopelessness
6. Vital exhaustion
7. Self-reported adherence to heart failure self-management
Sources of funding German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany) (ref: 01GI0205/21)
Trial website http://www.klinikum.uni-heidelberg.de/HELPS.105744.0.html#c36863
Publications
Contact name Prof  Wolfgang  Herzog
  Address Department of Psychosomatic and General Internal Medicine
Medical Hospital
University of Heidelberg
INF 410
  City/town Heidelberg
  Zip/Postcode 69120
  Country Germany
  Email Wolfgang.Herzog@med.uni-heidelberg.de
Sponsor German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)
  Address Hannoversche Str. 28-30
  City/town Berlin
  Zip/Postcode 10115
  Country Germany
  Sponsor website: http://www.bmbf.de/en/index.php
Date applied 30/03/2007
Last edited 30/05/2007
Date ISRCTN assigned 30/05/2007
Submit your trial protocol
Submit to Trials journal
© ISRCTN


BioMed Central